Status:
COMPLETED
Creatine Treatment in Psychiatric Disorders
Lead Sponsor:
Beersheva Mental Health Center
Collaborating Sponsors:
National Alliance for Research on Schizophrenia and Depression
Conditions:
Schizophrenia
Eligibility:
All Genders
18-60 years
Phase:
PHASE3
Brief Summary
Creatine plays a pivotal role in brain energy homeostasis. Creatine supplementation is widely used in enhancing sports performance, and has been tried in the treatment of neurological, neuromuscular a...
Detailed Description
Creatine plays a pivotal role in brain energy homeostasis, being a temporal and spatial buffer for cytosolic and mitochondrial pools of the cellular energy currency adenosine triphosphate (Wyss \& Kad...
Eligibility Criteria
Inclusion
- age 18-60
- physically healthy
- at least 2 years of illness in a stable condition
- presenting negative and cognitive symptoms
Exclusion
- drug or alcohol abuse
- clinically significant medical condition
- laboratory abnormality
Key Trial Info
Start Date :
September 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2006
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT00140192
Start Date
September 1 2004
End Date
March 1 2006
Last Update
July 29 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beersheva Mental Health Center
Beersheva, Israel